Related Experiment Video
Updated: May 22, 2026

Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis
Published on: May 12, 2019
[Urological cancers: ECCO/ESMO congress 2011]
Nabil Ismaili1, Said Afqir, Rhizlane Belbaraka
1Centre régional d'oncologie, hôpital Hassan II, département d'oncologie médicale, Agadir 80000, Maroc. ismailinabil@yahoo.fr
Innovative treatments for prostate cancer, including abiraterone acetate and sipuleucel-T, were presented. Research also highlighted genetic polymorphisms predicting anti-angiogenic efficacy in renal clear cell carcinoma.
Area of Science:
- Oncology
- Urology
Background:
- The European Cancer Organisation (ECCO)/European Society for Medical Oncology (ESMO) congress in Stockholm (September 2011) focused on advancements in urological cancer research.
- Key updates aimed to revolutionize patient management strategies for various urological malignancies.
Framework:
- Prostate Cancer: Abiraterone acetate recommended for post-docetaxel patients; sipuleucel-T for asymptomatic/minimally symptomatic castrate-resistant prostate cancer.
- Bone Metastases: Alpharadine suggested for symptomatic bone metastases; denosumab for high-risk non-metastatic prostate cancer patients.
- Renal Cell Carcinoma: Genetic polymorphisms identified as predictive biomarkers for anti-angiogenic agent efficacy.
Implementation:
- Dual targeting of vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF) pathways shows significant promise in metastatic renal clear cell carcinoma.
- Belinostat and bortezomib emerged as promising therapeutic agents for urothelial cancer.
Implications:
- These findings represent significant progress in urological cancer treatment, offering new therapeutic avenues and personalized medicine approaches.
- Further research and clinical trials are anticipated to validate and implement these innovative strategies for improved patient outcomes.
Related Concept Videos
Urologic Endoscopic Procedure: Cystoscopic Examination
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Cancer
Treatment Resistant Cancers
